WT1-AS and LEF1-AS1 are antisense transcripts of two PCGs, WT1 (Wilms tumor 1) and LEF1 (lymphoid enhancer binding factor 1), which belong among the strongest candidate genes showing an association with the prognosis of MDS patients [20]. The gene discussed is WT1; the disease is myelodysplastic syndrome.